Cargando...

Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma

Feline mammary carcinoma (FMC) is a common neoplasia in cat, being HER2-positive the most prevalent subtype. In woman’s breast cancer, tyrosine kinase inhibitors (TKi) are used as a therapeutic option, by blocking the phosphorylation of the HER2 tyrosine kinase domain. Moreover, clinical trials demo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmaceutics
Main Authors: Gameiro, Andreia, Almeida, Filipe, Nascimento, Catarina, Correia, Jorge, Ferreira, Fernando
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8002158/
https://ncbi.nlm.nih.gov/pubmed/33800900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030346
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!